Suppr超能文献

突破界限:一例罕见的胶质母细胞瘤伴不常见的神经外转移:病例报告及文献综述

Breaking boundaries: A rare case of glioblastoma with uncommon extraneural metastases: A case report and literature review.

作者信息

Taule Erlend Moen, Brekke Jorunn, Miletic Hrvoje, Sætran Hege, Maric Snezana, HogenEsch Ineke, Mahesparan Rupavathana

机构信息

Department of Biomedicine, University of Bergen, Jonas Lies Vei 91, 5009, Bergen, Norway.

Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.

出版信息

Brain Spine. 2024 Oct 10;4:103927. doi: 10.1016/j.bas.2024.103927. eCollection 2024.

Abstract

INTRODUCTION

Extraneural metastases (ENM) from glioblastoma (GBM) remain extremely rare with only a scarce number of cases described in the literature. The lack of cases leads to no consensus on the optimal treatment and follow-up of these patients.

RESEARCH QUESTION

Do patient or tumor characteristics describe risk factors for ENM in GBM patients, and is it possible to identify mechanisms of action?

MATERIAL AND METHODS

This study presents a 55-year-old man with diagnosed GBM who was referred to a CT due to reduced general condition and mild back pain which revealed extensive systemic metastases. A literature review was conducted to identify potential patient or tumor characteristics that may serve as risk factors for metastasis.

RESULTS

ENM from GBM are likely underreported, with limited examples in the literature and low survival rates of only a few months. Certain clinical and histopathological factors, such as male sex, younger age, temporal lobe location, and specific biological markers, have been associated with a higher likelihood of metastasis formation. Bone and/or bone marrow metastases are the most common sites. Despite various treatment regimens being attempted, there is no consensus on the optimal therapeutic approach for this patient group.

CONCLUSION

Clinical and histopathological factors can aid clinicians in recognizing the potential for ENM in GBM patients. Our review identifies some of the possible patient- and tumor-related risk factors. However, further research is crucial to identify specific molecular markers and elucidate the underlying biological mechanisms that is essential for development of targeted therapies.

摘要

引言

胶质母细胞瘤(GBM)的神经外转移(ENM)极为罕见,文献中仅描述了少数病例。病例稀缺导致对于这些患者的最佳治疗和随访尚无共识。

研究问题

患者或肿瘤特征是否可描述GBM患者发生ENM的风险因素,以及是否有可能确定其作用机制?

材料与方法

本研究报告了一名55岁确诊为GBM的男性患者,因全身状况下降和轻度背痛转诊至CT检查,结果显示有广泛的全身转移。进行了文献综述以确定可能作为转移风险因素的潜在患者或肿瘤特征。

结果

GBM的ENM可能报告不足,文献中的例子有限,生存率仅为几个月。某些临床和组织病理学因素,如男性、较年轻、颞叶位置和特定生物标志物,与转移形成的可能性较高相关。骨和/或骨髓转移是最常见的部位。尽管尝试了各种治疗方案,但对于该患者群体的最佳治疗方法尚无共识。

结论

临床和组织病理学因素可帮助临床医生识别GBM患者发生ENM的可能性。我们的综述确定了一些可能与患者和肿瘤相关的风险因素。然而,进一步的研究对于确定特定分子标志物和阐明潜在生物学机制至关重要,这对于开发靶向治疗至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e5/11736052/44feef272e71/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验